ARCHIVES

Blincyto Demonstrates Response In Minimal Residual Disease ALL

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

NCI To Test 5,000 DC-Area Jews To Determine Risk Of BRCA 1 Mutation

October 6, 1995

NCI Study Tests Donor T Cells Against Breast Cancer

August 29, 2003

ASCO Supports Tobacco Tax Increase

March 7, 2003

In Brief: Wyeth-Ayerst To donate hormone Replacement Therapy To NIH For Women’s Health Initiative

April 23, 1993

AIDS Research Loan Repayment Program

January 10, 1992

Drug Approvals: FDA Approves Vectibix in mCRC With KRAS Companion Diagnostic

May 30, 2014